Polymorphisms or haplotypes in HSD17B1 have been associated with increased risk for estrogen receptor-negative breast cancer, endometriosis, and endometrial cancer, but these associations have been modest and inconsistent [13, 15–32]. The gene discussed is ESR1; the disease is endometrial cancer.